Literature DB >> 10392357

Blood-brain barrier for human growth hormone and insulin-like growth factor-I.

M Coculescu1.   

Abstract

There is a blood-brain barrier (BBB) for GH. A certain, unknown amount of GH passes the BBB, acts on the neuronal GH receptors and directly influences the brain mechanisms serving the feedback and ultradian secretion of GH. The high density of GH receptors in the choroid plexus suggests a possible receptor-mediated transcytosis transport. The effects of GH on brain development, neuronal plasticity and neuroprotection seem to be mediated by IGFs. GH and IGFs are also synthesized in the brain. The relative contributions to brain functions of GHs produced inside and outside the BBB are unknown. The cerebrospinal fluid (CSF) space is the compartment inside the barrier accessible to clinicians. High GH levels in CSF were reported in acromegaly and also a small increase was reported after chronic administration of hGH in GH-deficiency syndromes. For the practitioner it is necessary to determine the normal range of hGH levels in CSF.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10392357     DOI: 10.1515/jpem.1999.12.2.113

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  17 in total

Review 1.  Extrapituitary growth hormone.

Authors:  S Harvey
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

2.  A pegylated growth hormone receptor antagonist, pegvisomant, does not enter the brain in humans.

Authors:  Johannes D Veldhuis; Martin Bidlingmaier; Joy Bailey; Dana Erickson; Paola Sandroni
Journal:  J Clin Endocrinol Metab       Date:  2010-05-05       Impact factor: 5.958

Review 3.  Growth hormone and cognitive function.

Authors:  Fred Nyberg; Mathias Hallberg
Journal:  Nat Rev Endocrinol       Date:  2013-04-30       Impact factor: 43.330

4.  Growth hormone rescues hippocampal synaptic function after sleep deprivation.

Authors:  Eunyoung Kim; Lawrence M Grover; Don Bertolotti; Todd L Green
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-03-17       Impact factor: 3.619

Review 5.  Neural growth hormone: an update.

Authors:  Steve Harvey; Kerry Hull
Journal:  J Mol Neurosci       Date:  2003-02       Impact factor: 3.444

6.  The association between peripheral total IGF-1, IGFBP-3, and IGF-1/IGFBP-3 and functional and cognitive outcomes in the Mayo Clinic Study of Aging.

Authors:  Alexandra M V Wennberg; Clinton E Hagen; Mary M Machulda; John H Hollman; Rosebud O Roberts; David S Knopman; Ronald C Petersen; Michelle M Mielke
Journal:  Neurobiol Aging       Date:  2018-02-19       Impact factor: 4.673

7.  Obesity induces functional astrocytic leptin receptors in hypothalamus.

Authors:  Hung Hsuchou; Yi He; Abba J Kastin; Hong Tu; Emily N Markadakis; Richard C Rogers; Paul B Fossier; Weihong Pan
Journal:  Brain       Date:  2009-03-17       Impact factor: 13.501

Review 8.  Somatotropic signaling: trade-offs between growth, reproductive development, and longevity.

Authors:  Andrzej Bartke; Liou Y Sun; Valter Longo
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

9.  Adult-onset deficiency in growth hormone and insulin-like growth factor-I alters oligodendrocyte turnover in the corpus callosum.

Authors:  Kun Hua; M Elizabeth Forbes; Robin J Lichtenwalner; William E Sonntag; David R Riddle
Journal:  Glia       Date:  2009-08-01       Impact factor: 7.452

10.  Macroscopic brain architecture changes and white matter pathology in acromegaly: a clinicoradiological study.

Authors:  C Sievers; P G Sämann; T Dose; C Dimopoulou; D Spieler; J Roemmler; J Schopohl; M Mueller; H J Schneider; M Czisch; H Pfister; G K Stalla
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.